Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial – the potential of enantiomeric separation for doping control analysis - Publication - Bridge of Knowledge

Search

Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial – the potential of enantiomeric separation for doping control analysis

Abstract

The differentiation of clenbuterol abuse and unintentional ingestion by contaminated meat is crucial with respect to the valuation of an adverse analytical finding in human sports doping control. The proportion of the two enantiomers of clenbuterol may serve as potential discriminating parameter. For the determination of the individual enantiomers, specific methods were developed and validated for the different matrices under investigation based on chiral chromatography coupled to tandem mass spectrometry. Data from the administration of clenbuterol from a pharmaceutical preparation and from cattle meat and liver containing residues to humans are presented. A shift in the proportion of the enantiomers in cattle meat is detected and this signature is also found in human urine after ingestion. Thus, an altered enantiomeric composition of clenbuterol may be used to substantiate athletes’ claims following adverse analytical findings in doping control. However, in meat, the enantiomeric composition was found to be highly variable. Species as well as tissue dependent variances need to be considered in interpreting enantiomer discrimination. Post administration urine from a controlled experiment comparing the administration of racemic clenbuterol from a registered pharmaceutical preparation and the administration of residue containing meat and liver from treated animals (nonracemic mixture) is reported. Furthermore doping control samples from Mexican U17 World Championship 2011 of the Fédération Internationale de Football Association (FIFA), with adverse analytical findings for clenbuterol, were reanalysed

Citations

  • 4 7

    CrossRef

  • 0

    Web of Science

  • 4 6

    Scopus

Authors (9)

  • Photo of  Maria K. Parr

    Maria K. Parr

    • Freie Universitat Berlin
  • Photo of  Marco Blokland

    Marco Blokland

    • RIKILT Wageningen UR
  • Photo of  Franz Liebetrau

    Franz Liebetrau

    • RIKILT Wageningen UR
  • Photo of  Alexander Schmidt

    Alexander Schmidt

    • Freie Universitat Berlin
  • Photo of  Thijs Meijer

    Thijs Meijer

    • Freie Universitat Berlin
  • Photo of  Mijo Stanic

    Mijo Stanic

    • Chromicent GmbH
  • Photo of dr inż. Dorota Kwiatkowska

    Dorota Kwiatkowska dr inż.

    • Institute of Sopot National Research Institute
  • Photo of  Emilia Waraksa

    Emilia Waraksa

    • Institute of Sopot National Research Institute
  • Photo of  Saskia Sterk

    Saskia Sterk

    • RIKILT Wageningen UR

Cite as

Full text

full text is not available in portal

Keywords

Details

Category:
Articles
Type:
artykuł w czasopiśmie wyróżnionym w JCR
Published in:
Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure& Risk Assessment no. 34, edition 4, pages 525 - 535,
ISSN: 1944-0049
Language:
English
Publication year:
2017
Bibliographic description:
Parr M., Blokland M., Liebetrau F., Schmidt A., Meijer T., Stanic M., Kwiatkowska D., Waraksa E., Sterk S.: Distinction of clenbuterol intake from drug or contaminated food of animal origin in a controlled administration trial – the potential of enantiomeric separation for doping control analysis// Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure& Risk Assessment. -Vol. 34, iss. 4 (2017), s.525-535
DOI:
Digital Object Identifier (open in new tab) 10.1080/19440049.2016.1242169
Verified by:
Gdańsk University of Technology

seen 182 times

Recommended for you

Meta Tags